🇺🇸 Emthexate in United States

79 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyspnoea — 11 reports (13.92%)
  2. Pyrexia — 11 reports (13.92%)
  3. Fatigue — 10 reports (12.66%)
  4. Headache — 9 reports (11.39%)
  5. Back Pain — 7 reports (8.86%)
  6. Pain — 7 reports (8.86%)
  7. Asthenia — 6 reports (7.59%)
  8. Nausea — 6 reports (7.59%)
  9. Oral Pain — 6 reports (7.59%)
  10. Osteonecrosis Of Jaw — 6 reports (7.59%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Emthexate approved in United States?

Emthexate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Emthexate in United States?

Dokuz Eylul University is the originator. The local marketing authorisation holder may differ — check the official source linked above.